Insulin glargine is produced by recombinant DNA technology ... 4 to 6.7. It results in an insulin molecule less soluble at the injection site, that precipitates in the subcutaneous tissue forming ...

Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis ...

Novo yesterday presented preliminary data which showed the formulation, O1338GT, is as effective as Sanofi’s insulin injectable Lantus in controlling blood glucose levels. But the Denmark ...

and neither have on this occasion gained approval for patients who are new to injectable therapy. Sanofi may have most to lose, however, as Lantus is the biggest selling standalone long-acting ...

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the ...

The Egyptian Drug Authority has granted approval for EVA Pharma’s insulin glargine injection, developed in collaboration with Eli Lilly and Company (NYSE:LLY). This approval marks an important ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

There are more options available than just the standard methods. Choices need to be made for every step of the injection procedure. KOLOA, Hawaii — Retina specialists have a lot of options when ...

A research team has developed an innovative injectable adhesive hydrogel for bone regeneration. This hydrogel utilizes harmless visible light to simultaneously achieve cross-linking and ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...